CAS 1386913-72-9 Patisiran Sodium

Patisiran Sodium

Patisiran sodium is a double-stranded small interfering RNA that targets a sequence within the transthyretin (TTR) messenger RNA. Patisiran sodium specifically inhibits hepatic synthesis of mutant and wild-type TTR. Patisiran sodium can be used for the research of hereditary TTR amyloidosis.

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Ordering Information

Catalog Number	Size	Price	Stock	Quantity
BRP-02066	5 mg	$1498	In stock

Add to cart

Catalog

BRP-02066

Synonyms

RNA, (A-U-G-G-A-A-Um-A-C-U-C-U-U-G-G-U-Um-A-C-dT-dT), complex with RNA (G-Um-A-A-Cm-Cm-A-A-G-A-G-Um-A-Um-Um-Cm-Cm-A-Um-dT-dT), sodium salt (1:1:40); Onpattro; siRNA ALN-18328

CAS

1386913-72-9

Molecular Weight

13427.10 (AS: 6661.3; SS: 6765.8)

Purity

95% by SEC-HPLC

Solubility

Soluble in Water

Appearance

Off-white to Light Yellow Solid

Storage

Store at -20 °C, stored under nitrogen

Sequence

RNA, (auggaauacucuugguuactt), complex with RNA (guaaccaagaguauuccautt), sodium salt (1:1:40)

Related CAS

1420706-45-1 (free acid)

Patisiran Sodium - CAS 1386913-72-9

Patisiran Sodium